Table 1.
Group | Baseline | 30-min Isch | 180-min Rep |
---|---|---|---|
Control (group I) | |||
HR | 182 ± 6 | 172 ± 9 | 155 ± 8 |
MAP | 86 ± 9 | 78 ± 8 | 71 ± 8 |
RPP | 20,924 ± 2348 | 17,168 ± 2425 | 14,020 ± 2253 |
Sildenafil (groupII) | |||
HR | 198 ± 9 | 187 ± 8 | 161 ± 9a |
MAP | 82 ± 10 | 66 ± 4 | 63 ± 5 |
RPP | 19,408 ± 1439 | 14,960 ± 2764 | 13,236 ± 3112 |
Sildenafil+5-HD (group III) | |||
HR | 191 ± 8 | 186 ± 7 | 159 ± 14 |
MAP | 84 ± 7 | 72 ± 6 | 67 ± 2 |
RPP | 18,996 ± 1180 | 16,182 ± 1350 | 13,720 ± 1053a |
Vardenafil (group IV) | |||
HR | 188 ± 7 | 179 ± 12 | 146 ± 10a,b |
MAP | 89 ± 4 | 71 ± 3a | 60 ± 3a,b |
RPP | 19,740 ± 1563 | 15,380 ± 2170 | 10,804 ± 1235a |
Vardeafnil+5-HD (group V) | |||
HR | 181 ± 6 | 185 ± 8 | 160 ± 9 |
MAP | 79 ± 4 | 74 ± 5 | 63 ± 7 |
RPP | 17,652 ± 2080 | 16,650 ± 1460 | 12,320 ± 1833 |
5-HD (group VI) | |||
HR | 190 ± 11 | 185 ± 8 | 160 ± 7 |
MAP | 75 ± 6 | 67 ± 5 | 61 ± 3 |
RPP | 17900 ± 1142 | 14,215 ± 2055 | 11,840 ± 1788 |
Nitroglycerin (group VII) | |||
HR | 178 ± 16 | 185 ± 8 | 160 ± 7 |
MAP | 85 ± 5 | 77 ± 5 | 72 ± 7 |
RPP | 18,154 ± 1912 | 16,617 ± 1462 | 13,360 ± 1743 |
Values are Means±SEM. HR – Heart rate (beats/min); MAP – Mean arterial blood pressure (mmHg); RPP – Rate pressure product (mmHg/min),
P < 0.05 vs. Baseline;
P < 0.05 vs. 30 min. Ischemia.